IKT Hisse Senedi Fiyat Grafiği
IKT Kazanmak
Inhibikase Therapeutics Inc
$1.84
-2.38%
$-0.04
Bugün itibarıyla:Apr 28, 12:03:57 GMT-4
Geri
Inhibikase Therapeutics Inc (IKT) Kazanmak
Önemli İstatistikler
Önceki Kapanış
$1.89
Açılış fiyatı
$1.89
Günün Aralığı
$1.84 - $1.89
52 haftalık aralık
$1.33 - $2.36
İşlem hacmi
188.4K
Ort.Hacim
1.5M
Dividend yield
--
EPS (TTM)
-1.15
Piyasa Değeri
$243.5M
IKT nedir?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 15 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
Özellikler
Kaynaklar
© 2026 Finture Development Limited. Tüm hakları saklıdır.